Pacific Edge’s American dream

Pacific Edge’s American dream
The US Affordable Care Act can be tricky to navigate. (Image: Getty)
Paul McBeth
Pacific Edge has long wanted to crack the United States market, which it has seen for a long time as validating the hundreds of millions spent in developing its Cxbladder non-invasive cancer detection tool. More than 20 years since listing, after it was spun out of University of Otago research, the company has raised $297.23 million selling shares and convertible preference shares and as people exercised options to fund accumulated losses of $216.8m and counting. That’s not going to change any time soon after the company crashed...

More Markets

NZ sharemarket ends week up 0.5%
Markets Market Close

NZ sharemarket ends week up 0.5%

The S&P/NZX 50 Index closed at 12,995.01, up 66.63 points.

Graham Skellern 31 Jan 2025
Minority investors need stronger protection – NZSA
Markets

Minority investors need stronger protection – NZSA

Hotels takeover offer shows need for minority shareholders voting regime. 

Rebecca Howard 31 Jan 2025
Receivers launch webpage for potential buyers of Ubco
Markets

Receivers launch webpage for potential buyers of Ubco

'Savvy investors' invited to secure Kiwi electronic-motorbike 'ingenuity'.

John Anthony 31 Jan 2025
Cannabis rule change having impact
Primary Sector

Cannabis rule change having impact

Regulatory changes in NZ and Germany have made NZ products more available worldwide.

Murray Jones 31 Jan 2025